Evidence map›Paper›PMID 35628460›Full record

ReviewInternational journal of molecular sciences2022

The Advances in Epigenetics for Cancer Radiotherapy.

Yuexuan Wang, Yu Han, Yuzhen Jin, Qiang He, Zhicheng Wang

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuexuan WangNHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130021, China.
Yu HanNHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130021, China.
Yuzhen JinNHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130021, China.
Qiang HeNHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130021, China.
Zhicheng WangNHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130021, China.ORCID 0000-0002-7617-3165

Funding

Jilin Health Technology Innovation 2020SCZT066
6 · The paper itself

Abstract

Cancer is an important factor threatening human life and health; in recent years, its morbidity and mortality remain high and demosntrate an upward trend. It is of great significance to study its pathogenesis and targeted therapy. As the complex mechanisms of epigenetic modification has been increasingly discovered, they are more closely related to the occurrence and development of cancer. As a reversible response, epigenetic modification is of great significance for the improvement of classical therapeutic measures and the discovery of new therapeutic targets. It has become a research focusto explore the multi-level mechanisms of RNA, DNA, chromatin and proteins. As an important means of cancer treatment, radiotherapy has made great progress in technology, methods, means and targeted sensitization after years of rapid development, and even research on radiotherapy based on epigenetic modification is rampant. A series of epigenetic effects of radiation on DNA methylation, histone modification, chromosome remodeling, RNA modification and non-coding RNA during radiotherapy affects the therapeutic effects and prognosis. Starting from the epigenetic mechanism of tumorigenesis, this paper reviews the latest progress in the mechanism of interaction between epigenetic modification and cancer radiotherapy and briefly introduces the main types, mechanisms and applications of epigenetic modifiers used for radiotherapy sensitization in order to explore a more individual and dynamic approach of cancer treatment based on epigenetic mechanism. This study strives to make a modest contribution to the progress of human disease research.

Indexed as

EpigenomicsNeoplasmsChromatinDNA MethylationEpigenesis, GeneticHumansRNAChromatinRNAchromatin remodelingDNA methylationepigenetic modificationhistone modificationradiotherapyRNA modification

Identifiers

PMID35628460
PMCPMC9145982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.